Embla Medical hf: Conference call details for Q3 2026

Reykjavik, Iceland/Copenhagen, Denmark, 6 October 2026. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2026 Report on October 20, 2026, at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST. The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English. Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors To participate in the telephone conference, please use the dial-in details provided below: DK: +45 78 76 84 90 SE: +46 31-311 50 03 UK: +44 20 3769 6819 US: +1 646 787 0157 Participant access code: 274982 The webcast will be available through following link: Embla Medical Q3 2026 webcast Financial calendar and events 2026/2027 October 20, 2026 Interim Report Q3 2026 October 20, 2026 Q3 2026 Presentation & Q&A, virtual (HC Andersen Capital) October 20, 2026 Q3 2026 Investor Road Show, Copenhagen (Danske Bank) October 21, 2026 Q3 2026 Investor Road Show, Helsinki (ABG) October 21, 2026 Q3 2026 Virtual Investor Road Show (Nordea) October 26 2026 Q3 2026 Investor Road Show, Reykjavik (Embla HQ) November 10, 2026 Berenberg Nordic Seminar, Paris November 18-19, 2026 Jefferies Global Healthcare Conference, London November 24. 2026 Aktie-Info Investor event (retail), Kolding Denmark November 26, 2026 Danske Bank Winter Seminar, Copenhagen January 11, 2027 SEB Nordic Seminar, Copenhagen February 2, 2027 Q4 Report 2026 & 2026 Annual Report March 2, 2027 UBS European Healthcare Conference, London March 17, 2027 DNB Carnegie Healthcare Conference, Stockholm If you wish to receive Embla Medical press releases by e-mail, please register here For further information please contact Klaus Sindahl Head of Investor Relations M: +45 5363 0134 E: ksindahl@emblamedical.com About Embla Medical Embla Medical (Nasdaq Copenhagen: EMBLA) was founded in Reykjavik in 1971 with the mission to improve people's mobility. Embla Medical is home to several brands renowned for positively impacting people's health and well-being. They include Össur, a leading global provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park Industries, creators of custom-built prosthetic solutions. Embla Medical also provides patients with world-class care through a global network of Orthotic and Prosthetic (O&P) facilities. Embla Medical is committed to sustainable business practices and is signatory to the UN Global Compact, UN Women’s Empowerment Principles, and contributes to the UN Sustainable Development Goals. The company's climate targets have been verified by the Science Based Targets initiative. Embla Medical operates globally and has more than 4,000 employees. www.emblamedical.com